ANALYSIS AND IMPROVEMENT OF PRESCRIPTION AND ADMINISTRATION IN HOSPITAL TRANSITIONS
PS-064
IMPACT OF REMEDIAL ACTIONS AFTER A RISK ANALYSIS BY A FAILURE MODE EFFECTS AND CONSEQUENCES ANALYSIS ON PHARMACEUTICAL INTERVENTIONS IN A PAEDIATRIC HOSPITAL
PS-039
ESSENTIAL MEDICINES BY THE WORLD HEALTH ORGANISATION AND THEIR CONVENIENCE IN ELDERLY PATIENTS
PS-108
DOES THE COMPLETION OF A RISK ASSESSMENT TEMPLATE IMPROVE THE RATE OF APPROPRIATE VENOUS THROMBOEMBOLISM RISK MANAGEMENT FOR HOSPITALISED MEDICAL PATIENTS?
PS-106
LOOK-ALIKE AND SOUND-ALIKE DRUG INCIDENTS IN A HOSPITAL: A RETROSPECTIVE ANALYSIS
PS-104
MEDICATION RECONCILIATION : WHICH SELECTION CRITERIA IN PSYCHIATRY?
PS-103
OPTIMIZATION OF THE DRUG PRESCRIPTION PROCESS IN PATIENT ADMISSION
PS-100
PROTOCOLISED MEDICATION AFTER DISCHARGE FROM AN EMERGENCY DEPARTMENT
PS-098
REORGANIZATION OF MEDICATION CIRCUIT IN THE OPERATING AND DELIVERY ROOM
PS-097
A COMPARATIVE STUDY BETWEEN INVESTIGATOR SAFETY DATA AND A PHARMACOVIGILANCE DATABASE: A KEY ROLE OF THE PHARMACOVIGILANT IN THE RELEVANCY OF CLINICAL TRIAL PUBLICATIONS
PS-096
METHADONE AND LEVOMETHADONE: RISKS AND COSTS ANALYSES
PS-095
ANALYSIS OF MATERIOVIGILANCE BOTTOM UP ALERTS RELATED TO MEDICAL PERFUSION DEVICES
PS-094
PHARMACEUTICAL VALIDATION OF MEDICATION ORDERS IN AN EMERGENCY DEPARTMENT OBSERVATION UNIT. RECOMMENDATIONS AND DEGREE OF ACCEPTANCE.
PS-093
COLLABORATIVE EFFORT WITHIN A MULTIDISCIPLINARY HEART FAILURE TEAM
PS-091
MEDICATION INDUCED SIADH: DISTRIBUTION AND CHARACTERIZATION ACCORDING TO MEDICATION CLASS
